Your browser doesn't support javascript.
loading
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study.
Feagan, Brian G; Panés, Julián; Ferrante, Marc; Kaser, Arthur; D'Haens, Geert R; Sandborn, William J; Louis, Edouard; Neurath, Markus F; Franchimont, Denis; Dewit, Olivier; Seidler, Ursula; Kim, Kyung-Jo; Selinger, Christian; Padula, Steven J; Herichova, Ivona; Robinson, Anne M; Wallace, Kori; Zhao, Jun; Minocha, Mukul; Othman, Ahmed A; Soaita, Adina; Visvanathan, Sudha; Hall, David B; Böcher, Wulf O.
  • Feagan BG; Western University, Robarts Clinical Trials, London, ON, Canada. Electronic address: brian.feagan@robartsinc.com.
  • Panés J; Hospital Clinic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
  • Ferrante M; University Hospitals Leuven, Leuven, Belgium.
  • Kaser A; University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • D'Haens GR; Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • Sandborn WJ; University of California San Diego, La Jolla, CA, USA.
  • Louis E; University Hospital CHU Liège, Liège, Belgium.
  • Neurath MF; University of Erlangen-Nuremberg, Erlangen, Germany.
  • Franchimont D; Erasme University Hospital, Brussels, Belgium.
  • Dewit O; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Seidler U; Hannover Medical School, Hannover, Germany.
  • Kim KJ; Asan Medical Center, Seoul, South Korea.
  • Selinger C; St James's University Hospital, Leeds, UK.
  • Padula SJ; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany.
  • Herichova I; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Robinson AM; AbbVie Inc, North Chicago, IL, USA.
  • Wallace K; AbbVie Inc, North Chicago, IL, USA.
  • Zhao J; AbbVie Inc, North Chicago, IL, USA.
  • Minocha M; AbbVie Inc, North Chicago, IL, USA.
  • Othman AA; AbbVie Inc, North Chicago, IL, USA.
  • Soaita A; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.
  • Visvanathan S; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.
  • Hall DB; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.
  • Böcher WO; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany.
Lancet Gastroenterol Hepatol ; 3(10): 671-680, 2018 10.
Article en En | MEDLINE | ID: mdl-30056030
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Subunidad p19 de la Interleucina-23 / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Subunidad p19 de la Interleucina-23 / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article